Hataali

powered by ATMPS Ltd

Decoding the Complexity of Cell and Gene Therapies

One Platfrom - Multiple Therapies Sites Stakeholders

Increasing access to cell and gene therapies worldwide, through future-proof techologies

Hataali provides a comprehensive technical solution that simplifies the complexities of cell and gene therapies. Our modular, holistic solution streamlines the process for pharmaceutical companies, research institutions, medical centers, and logistics companies, ensuring the safety and efficacy of personalized treatments through digitization and automation utilizing blockchain and AI.

Doctor using Hataali a blockchain solution for cell and gene therapy

Streamlining the Cell and Gene Therapy complexities by enhancing collaboration, saving time, and empowering Therapy Developers, Clinics, and Researchers to work seamlessly in a centralized digital hub.

Doctor looking at statistic for on Hataali cell and gene platform

Hataali Solution

Hataali is a future-proof, patented blockchain technology solution designed to ease the ordering, scheduling and administration of cell and gene therapies and make them accessible worldwide. With our configurable modules, we help streamline all aspects of personalized medicine, from data gathering to treatment, ensuring regulatory compliance, and data security, saving time and reducing costs.

Why you should work with us?

Hataali provides exactly what clinics, hospitals, labs, pharmaceutical companies, and specialist couriers need to streamline their processes, reduce errors, and increase data security in personalised medicine.

Our solution provides one digitalized platform that can be used by multiple stakeholders for multiple treatments, while remaining compliant with all regulations. Hataali patented  blockchain technology ensures that the data remains secure and private.

Benefits

Hataali Dashboard mock up

Hataali streamlines the entire Cell and Gene Therapy (CGT)  process for pharmaceutical companies, hospitals, clinics, logistics providers, and suppliers. Our universal platform offers automation, data analytics, and demand planning capabilities, going beyond a mere scheduling system. We provide an ecosystem for the entire cell and gene therapy sector.

Our holistic  Cell and Gene Therapy platform makes integration across different systems seamless, without the need for custom code. This eliminates the need for long implementation periods and additional costs of competitive solutions.

Hataali is the ultimate personalized medicine solution that harnesses the power of our patented blockchain technology, guaranteeing unparalleled levels of security, data privacy, and future proofing. Our innovative digital platform provides the most effective technical compliance tool available, giving you complete peace of mind.

Our service modules are configurable so that your company can build the solution to fit your specific needs with fast implementation times. It is cost effective and as you grow, you add modules as your business requires. Our product roadmap includes some of the most advanced and unique technical products for the cell and gene therapy sector.

With Hataali, you only pay for the modules and services you need. We have services suitable for the smaller labs to the largest pharma companies ensuring budget efficiency. We understand that personalized medicine can be expensive and we want to help make them more accessible and affordable for everyone.

Hataali brings together all the stakeholders involved in personalized medicine treatments, from patients to physicians to labs and logistics providers, ensuring everyone can communicate and coordinate to provide therapies more efficiently.

Hataali utilizes advanced technology to provide real-time information, including treatment details, progress through the supply chain  and personnel involved. , . By doing so, Hataali ensures that patients receive timely and appropriate treatments ensuring full Chain of Identity and Chain of Custody data records for compliance purposes. Moreover, real-time alerts enable swift resolution of any immediate problems or issues, leading to an improved patient experience.

Hataali Dashboard mock up

Our Clients

Hataali is a leading provider of secure, end-to-end platforms designed to streamline personalized medicine processes for all stakeholders involved in the cell and gene industry

Our platform offers a range of innovative features that enable healthcare providers, researchers, biotech companies, and patients to efficiently manage all types of cell and gene therapy development and delivery.

With our flexible and customizable platform, both small and large corporations can benefit from a streamlined, easy-to-use solution that enhances collaboration and drives efficiencies.

Labs and Pharma

For big pharmaceutical companies and small labs, Hataali’s configurable solutions provide a tailored approach that meets specific company needs. These solutions seamlessly integrate into existing workflows, reducing the time and resources required for adoption.

Specialist Courier

Specialist couriers are a critical component of personalized medicine transportation, especially for cell and gene therapies that require specialized handling and storage conditions.

Hataali’s blockchain solution integrates with the existing logistics infrastructure, making it easier and more efficient to manage and track the transportation of these therapies. The end-to-end solution ensures that all data generated during transportation is captured and secured on the blockchain, providing a transparent and auditable record of the entire process.

Clinics and Hospitals

For big and small hospitals, clinics, and treatment centres, Hataali’s live data access and updates provide a platform for all parties involved in a patient’s treatment to interact and see live updates and changes in the progress of the treatment. This ensures that mistakes and duplicates are eliminated from patients’ data entry, transportation, laboratory tests, and production. The result is faster, more efficient treatment that provides better outcomes for patients.

As seen in